Soluble receptors in human disease

被引:147
作者
Heaney, ML
Golde, DW
机构
[1] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Program Mol Therapeut, New York, NY 10021 USA
关键词
diagnosis; therapy; inhibitor; agonist; hormone; cytokine;
D O I
10.1002/jlb.64.2.135
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Soluble cytokine receptors naturally arise from genes encoding membrane-bound receptors or are direct derivatives of the receptors themselves. There is mounting evidence that soluble receptors play important roles in human disease states. In many cases, soluble receptors appear to play an integral part in the dynamic interaction between ligands and their membrane-bound receptors in maintaining and restoring health after a pathological insult but, in some instances, dysregulated expression of soluble receptors can contribute to disease pathology, Nonetheless, an appreciation of the biological actions of soluble receptors, particularly as cytokine inhibitors, has led to their therapeutic use in human diseases, Although early clinical trials of soluble receptors have had unexpected toxicities, their application in medicine continues to advance and. it is likely that soluble receptors will join hormones, cytokines, and growth factors as established biological therapies.
引用
收藏
页码:135 / 146
页数:12
相关论文
共 188 条
[41]  
Costa M, 1996, J CELL PHYSIOL, V168, P737, DOI 10.1002/(SICI)1097-4652(199609)168:3<737::AID-JCP27>3.0.CO
[42]  
2-U
[43]   Recombinant soluble interleukin-11 (IL-11) receptor alpha-chain can act as an IL-11 antagonist [J].
Curtis, DJ ;
Hilton, DJ ;
Roberts, B ;
Murray, L ;
Nicola, N ;
Begley, CG .
BLOOD, 1997, 90 (11) :4403-4412
[44]   SOLUBLE COMPLEMENT RECEPTOR-TYPE-1 (CD35) IS RELEASED FROM LEUKOCYTES BY SURFACE CLEAVAGE [J].
DANIELSSON, C ;
PASCUAL, M ;
FRENCH, L ;
STEIGER, G ;
SCHIFFERLI, JA .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1994, 24 (11) :2725-2731
[45]   Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein [J].
Dastot, F ;
Sobrier, ML ;
Duquesnoy, P ;
Duriez, B ;
Goossens, M ;
Amselem, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10723-10728
[46]   RELEASED FORM OF CNTF RECEPTOR-ALPHA COMPONENT AS A SOLUBLE MEDIATOR OF CNTF RESPONSES [J].
DAVIS, S ;
ALDRICH, TH ;
IP, NY ;
STAHL, N ;
SCHERER, S ;
FARRUGGELLA, T ;
DISTEFANO, PS ;
CURTIS, R ;
PANAYOTATOS, N ;
GASCAN, H ;
CHEVALIER, S ;
YANCOPOULOS, GD .
SCIENCE, 1993, 259 (5102) :1736-1739
[47]   THE RECEPTOR FOR CILIARY NEUROTROPHIC FACTOR [J].
DAVIS, S ;
ALDRICH, TH ;
VALENZUELA, DM ;
WONG, V ;
FURTH, ME ;
SQUINTO, SP ;
YANCOPOULOS, GD .
SCIENCE, 1991, 253 (5015) :59-63
[48]   Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130 [J].
Diamant, M ;
Rieneck, K ;
Mechti, N ;
Zhang, XG ;
Svenson, M ;
Bendtzen, K ;
Klein, B .
FEBS LETTERS, 1997, 412 (02) :379-384
[49]   SOLUBLE RECEPTORS FOR TUMOR-NECROSIS-FACTOR IN CLINICAL LABORATORY DIAGNOSIS [J].
DIEZRUIZ, A ;
TILZ, GP ;
ZANGERLE, R ;
BAIERBITTERLICH, G ;
WACHTER, H ;
FUCHS, D .
EUROPEAN JOURNAL OF HAEMATOLOGY, 1995, 54 (01) :1-8
[50]   Biologic basis for interleukin-1 in disease [J].
Dinarello, CA .
BLOOD, 1996, 87 (06) :2095-2147